| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.1M | -17.8% |
| R&D Expense | $225.4M | +60.2% |
| SG&A Expense | $82.8M | +38.4% |
| Operating Income | -$272.1M | -73.8% |
| Pre-tax Income | -$207.2M | -36.5% |
| Income Tax | $8.2M | +155.4% |
| Net Income | -$215.3M | -39.0% |
| EPS (Basic) | -$3.35 | -11.7% |
| EPS (Diluted) | -$3.35 | -11.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $293.3M | +43.6% |
| Short-term Investments | $243.7M | +62.3% |
| Accounts Receivable | $1.3M | -48.1% |
| Current Assets | $569.1M | +54.3% |
| Total Assets | $782.7M | +71.8% |
| Current Liabilities | $87.1M | +26.0% |
| Total Liabilities | $134.8M | +35.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$185.8M | -30.7% |
| Capital Expenditures | $1.7M | -58.1% |
| Investing Cash Flow | -$220.2M | -715.0% |
| Financing Cash Flow | $494.0M | +114.7% |
| Free Cash Flow | -$187.5M | -28.3% |
| Stockholders' Equity |
| $647.9M |
| +81.8% |